info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0141955 |
| CAS No | NA |
| Mol.F. | C23H29Cl2N5O |
| Mol.Wt. | 462.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141956 |
| CAS No | 53602-74-7 |
| Mol.F. | C13H13N3O4 |
| Mol.Wt. | 275.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141957 |
| CAS No | NA |
| Mol.F. | C11H11N3O3 |
| Mol.Wt. | 233.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141958 |
| CAS No | 68807-89-6 |
| Mol.F. | C11H11N3O3 |
| Mol.Wt. | 233.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141959 |
| CAS No | NA |
| Mol.F. | C12H17ClN2O2 |
| Mol.Wt. | 256.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141960 |
| CAS No | 13256-23-0 |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141961 |
| CAS No | NA |
| Mol.F. | C20H25N3O6 |
| Mol.Wt. | 403.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141962 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O |
| Mol.Wt. | 335.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141963 |
| CAS No | 2659259-64-8 |
| Mol.F. | C15H14N2O |
| Mol.Wt. | 238.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141964 |
| CAS No | NA |
| Mol.F. | C27H27F2N7O3 |
| Mol.Wt. | 535.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141965 |
| CAS No | NA |
| Mol.F. | C19H18Br2N6O3 |
| Mol.Wt. | 538.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141966 |
| CAS No | NA |
| Mol.F. | C15H18BrN5O5S |
| Mol.Wt. | 460.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141967 |
| CAS No | NA |
| Mol.F. | C19H19Br2N7O5S |
| Mol.Wt. | 617.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141968 |
| CAS No | NA |
| Mol.F. | C28H30Br2N10O8S2 |
| Mol.Wt. | 858.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141969 |
| CAS No | NA |
| Mol.F. | C13H13BrClN5O3S |
| Mol.Wt. | 434.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141970 |
| CAS No | NA |
| Mol.F. | C13H15N3O |
| Mol.Wt. | 229.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
